Review article: complementary and alternative therapies for inflammatory bowel disease.
about
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?Systematic review: the efficacy of herbal therapy in inflammatory bowel diseaseHerbal medicine in the treatment of ulcerative colitisProtective essential oil attenuates influenza virus infection: an in vitro study in MDCK cells.Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity.Use of complementary and alternative medicine: a survey in Turkish gastroenterology patients.Moxibustion for ulcerative colitis: a systematic review and meta-analysisA survey of perceptions and practices of complementary alternative medicine among Canadian gastroenterologistsFermented herbal formula KIOM-MA-128 protects against acute colitis induced by dextran sodium sulfate in mice.Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review.Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Advances in treatment of ulcerative colitis with herbs: from bench to bedsideNatural product-derived drugs for the treatment of inflammatory bowel diseases.Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?Differential effects of selective frankincense (Ru Xiang) essential oil versus non-selective sandalwood (Tan Xiang) essential oil on cultured bladder cancer cells: a microarray and bioinformatics studyAlteration of DSS-mediated immune cell redistribution in murine colitis by oral colostral immunoglobulinBovine colostrum increases pore-forming claudin-2 protein expression but paradoxically not ion permeability possibly by a change of the intestinal cytokine milieuDietary uptake of Wedelia chinensis extract attenuates dextran sulfate sodium-induced colitis in miceInvolvement of MAPK/NF-κB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulationNatural compound methyl protodioscin protects against intestinal inflammation through modulation of intestinal immune responses.Pharmacological basis for the use of Hypericum oblongifolium as a medicinal plant in the management of pain, inflammation and pyrexia.Validation and optimization of experimental colitis induction in rats using 2, 4, 6-trinitrobenzene sulfonic acidAngelica acutiloba Kitagawa Extract Attenuates DSS-Induced Murine Colitis.A review of complementary and alternative approaches to immunomodulation.Qing Hua Chang Yin attenuates lipopolysaccharide-induced inflammatory response in human intestinal cells by inhibiting NF-κB activation.Epidemiology and gene markers of ulcerative colitis in the Chinese.Fermented Pueraria Lobata extract ameliorates dextran sulfate sodium-induced colitis by reducing pro-inflammatory cytokines and recovering intestinal barrier function.Integrative medicine in gastrointestinal disease: evaluating the evidence.Boswellic acids: a group of medicinally important compounds.Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation.Use of complementary and alternative medicine by patients with inflammatory bowel disease.Integrated models of care in managing inflammatory bowel disease: a discussion.Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis.A review of the use of complementary and alternative medicines by children with inflammatory bowel disease.Kangfuxinye Enema Combined with Mesalamine for Ulcerative Colitis: A Systematic Review and GRADE Approach.Plant-derived polysaccharide supplements inhibit dextran sulfate sodium-induced colitis in the rat.Modified Pulsatilla decoction attenuates oxazolone-induced colitis in mice through suppression of inflammation and epithelial barrier disruption.Involvement of 5HT3 Receptors in Anti-Inflammatory Effects of Tropisetron on Experimental TNBS-Induced Colitis in Rat.Does Cisapride, as a 5HT(4) Receptor Agonist, Aggravate the Severity of TNBS-Induced Colitis in Rat?
P2860
Q26777641-B0B4F412-E231-4508-A236-2453BAD6B157Q27004516-0781E5B2-CD1D-4BBD-9CF1-51ABA391CEE2Q27022892-7B02F18A-1EF3-48D6-96DA-F329C42FDE89Q30396288-62F07BDE-DAA5-4087-8997-50869E3ED368Q33419487-6153C33A-86ED-4ED0-92A1-65CD96760CFEQ33512608-1250B73E-EFE2-42F1-AFE6-310C4915770EQ33550610-8E1B188E-6A3A-4F02-AE44-BEC223BC0F23Q33810124-ED00E6FC-43A9-4652-836A-1A96EE2EA9C0Q33877049-243C2E1A-E823-4873-B7A5-C07C4368AB7AQ34100569-4D75F3F5-94B3-4178-8110-A5DCEF1C77AAQ34101905-F8D9A48F-7FFE-4BCB-883B-D98A2DE866FBQ34152778-19767A89-AA19-410D-AD08-E4E0A42DD853Q34366829-43124031-E39D-453E-A36C-ACA85DDE64D5Q34378678-F551DBA6-4B10-4B02-A359-509E82265FC5Q34419462-F291EC38-690B-4F85-B514-5DC754169A8CQ34428422-7C97A2F2-D403-43B3-8B6B-2DD173862E4EQ34593298-84D237F3-A93E-420B-85DD-E9ABE80E5095Q34745430-E08EE4BF-2601-423B-BF90-22375C84FAD3Q34755383-0EF8CB3B-28B4-4AF5-8A3A-C757320773B0Q34924354-2F72434F-8064-41D4-BDF6-9F10CCA0310FQ35664929-ED96CF62-785F-40B9-8ECE-F5161F8274A2Q35911271-7B2AA228-F4EC-4DCF-A2B9-CD8191E09886Q36410864-224CC48C-69A0-47E7-8AD5-0B69D3A717BDQ36949171-6C95DD09-23CE-4CA0-A817-02368FA48FC0Q37060108-280C7DA8-92E7-40E1-97B1-4DD621944028Q37076294-4625C15C-B6EE-4072-952F-898E63145583Q37122384-0260F11B-CF0C-4555-B57F-36789C80E845Q37325113-B59809DD-0E75-415C-BA54-28154A8487D4Q37345889-EFE6B7B9-D3D5-4B9D-AAEA-72C84043F8E6Q37448772-053F288F-1314-47BD-B7D1-7E5242302384Q37662623-5E93BD20-02E6-4A6A-8710-347A8B6BAE95Q37789695-E397FE52-06DE-4C8F-99D3-2DB9E488BB8CQ37975468-50CF495F-2944-4106-A090-802FEA0558F4Q38016381-FFE953DF-72DB-47ED-ABDB-BD4FA6237A77Q38176623-C7017591-C3BA-490B-8137-A3BC271336BAQ40067106-34970C27-D7B3-4B83-8C97-A1B9D8C14C07Q40310518-AB059103-8629-49F4-8448-312FAAAEF6C0Q41834962-2FD3937B-CB78-4915-BC45-F89E17D7D936Q41873397-C2C80757-A01C-44AB-9C84-01FF1DD91FBEQ42255978-06CCA8A9-3F62-464D-9DC6-8286B7856198
P2860
Review article: complementary and alternative therapies for inflammatory bowel disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Review article: complementary and alternative therapies for inflammatory bowel disease.
@ast
Review article: complementary and alternative therapies for inflammatory bowel disease.
@en
type
label
Review article: complementary and alternative therapies for inflammatory bowel disease.
@ast
Review article: complementary and alternative therapies for inflammatory bowel disease.
@en
prefLabel
Review article: complementary and alternative therapies for inflammatory bowel disease.
@ast
Review article: complementary and alternative therapies for inflammatory bowel disease.
@en
P2860
P1476
Review article: complementary and alternative therapies for inflammatory bowel disease.
@en
P2093
Langmead L
Rampton DS
P2860
P304
P356
10.1111/J.1365-2036.2006.02761.X
P407
P577
2006-02-01T00:00:00Z